Scott Braunstein's Net Worth

$2.21 Million

Estimate Recalculated Mar 27, 2024 10:57AM EST

Who is Scott Braunstein?

Scott Braunstein has an estimated net worth of $2.21 Million. This is based on reported shares across multiple companies, which include ZIOPHARM ONCOLOGY INC, CONSTELLATION PHARMACEUTICALS INC, MARINUS PHARMACEUTICALS, INC., Caribou Biosciences, Inc., Esperion Therapeutics, Inc., Pacira Pharmaceuticals, Inc., TREVENA INC, and Protara Therapeutics, Inc..

SEC CIK

Scott Braunstein's CIK is 0001643875

Past Insider Trading and Trends

2020 was Scott Braunstein's most active year for acquiring shares with 13 total transactions. Scott Braunstein's most active month to acquire stocks was the month of December. 2021 was Scott Braunstein's most active year for disposing of shares, totalling 3 transactions. Scott Braunstein's most active month to dispose stocks was the month of June. 2019 saw Scott Braunstein paying a total of $125,000.00 for 1,433,089 shares, this is the most they've acquired in one year. In 2023 Scott Braunstein cashed out on 6,443 shares for a total of $61,512.35, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ZIOPHARM ONCOLOGY INC (TCRT) Snapshot price: $2.35

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
31.78K
—
—
31.78K
Dec 31
Form 4
—
0
—
—
0
Dec 31
Form 4
—
0
—
—
0
Sep 18
Form 3
—
0
—
—
0
No matching records found

CONSTELLATION PHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jul 15
Form 4
—
0
—
—
0
Jun 2
Form 4
—
0
—
—
0
Jun 4
Form 4
—
0
—
—
0
Feb 19
Form 3
—
0
—
—
0
No matching records found

MARINUS PHARMACEUTICALS, INC. (MRNS) Snapshot price: $9.92

CHAIRMAN AND CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+22.37%
50K
$4.28
$214,000.00
273.51K
Mar 27
Form 4
-5.03%
-11.85K
$9.94
-$117,789.00
223.51K
Feb 16
Form 4
+46.40%
74.6K
—
—
235.36K
Jan 18
Form 4
-3.85%
-6.44K
$9.55
-$61,512.35
160.76K
Aug 7 - Aug 8
Form 4
+91.74%
80K
—
—
167.21K
Jan 26
Form 4
+28.43%
19.3K
—
—
87.2K
May 24
Form 4
+171.60%
42.9K
—
—
67.9K
Feb 4
Form 4
—
0
—
—
0
Jan 15
Form 4
—
0
—
—
0
Jan 8
Form 4
∞
100K
$1.25
$125,000.00
100K
Dec 13
Form 4
—
0
—
—
0
Aug 6
Form 4
—
0
—
—
0
Feb 26
Form 3
—
0
—
—
0
No matching records found

Caribou Biosciences, Inc. (CRBU) Snapshot price: $6.7003

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 20
Form 4
—
0
—
—
0
Feb 21
Form 4
—
0
—
—
0
Dec 20
Form 3
—
0
—
—
0
No matching records found

Esperion Therapeutics, Inc. (ESPR) Snapshot price: $2.67

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+9,551.92%
4.97K
—
—
5.02K
May 29
Form 4
—
0
—
—
0
May 23
Form 4
—
0
—
—
0
Apr 17
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Aug 19
Form 3
—
0
—
—
0
No matching records found